CHC Healthcare Group (4164) Stock Overview
Trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
4164 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
CHC Healthcare Group Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$30.70 |
| 52 Week High | NT$53.80 |
| 52 Week Low | NT$29.90 |
| Beta | 0.20 |
| 1 Month Change | -6.97% |
| 3 Month Change | -20.26% |
| 1 Year Change | -37.98% |
| 3 Year Change | -55.05% |
| 5 Year Change | -17.91% |
| Change since IPO | -66.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4164 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | -3.2% | 1.0% | 4.1% |
| 1Y | -38.0% | -19.3% | 50.7% |
Return vs Industry: 4164 underperformed the TW Healthcare industry which returned -19.3% over the past year.
Return vs Market: 4164 underperformed the TW Market which returned 50.7% over the past year.
Price Volatility
| 4164 volatility | |
|---|---|
| 4164 Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 3.6% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in TW Market | 10.0% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 4164 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4164's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Ming-Lun Lee | www.chcg.com |
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supplements; elderly residence, long-term care, and senior services; leasing of veterinary medical instruments; department setup, business management consultation, and educational training and staff development for healthcare personnel; technical support and maintenance; radiation sterilization business; and online and physical store pharmacy chain activities.
CHC Healthcare Group Fundamentals Summary
| 4164 fundamental statistics | |
|---|---|
| Market cap | NT$6.04b |
| Earnings (TTM) | NT$186.28m |
| Revenue (TTM) | NT$4.40b |
Is 4164 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4164 income statement (TTM) | |
|---|---|
| Revenue | NT$4.40b |
| Cost of Revenue | NT$3.25b |
| Gross Profit | NT$1.15b |
| Other Expenses | NT$962.51m |
| Earnings | NT$186.28m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 26.12% |
| Net Profit Margin | 4.24% |
| Debt/Equity Ratio | 63.1% |
How did 4164 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 10:06 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CHC Healthcare Group is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jianzheng Wu | Capital Securities Corporation |
| Joseph Quinn | Macquarie Research |
| Xiaowei Huang | Masterlink Securities Corp. |
